USPTO serial 79328076
TRIALSCOPE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 20, 2024
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TRIALSCOPE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright Epstein Drangel LLP60 East 42nd Street, Suite 1250New York, NY 10165UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded and downloadable computer software for use by others for use in project management, providing an operations dashboard, workflow management, document library management, task management and using business intelligence to manage clinical trials; blank digital and analogue recording and storage media, namely, blank CD-ROMs for sound or video recording and blank digital storage media; Downloadable computer software to enable sponsors of clinical trials to collect, store, and analyze and generate reports from clinical trial data; Electronic database in the field of clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management recorded on computer media; downloadable digital multimedia files, namely, downloadable audio and video files featuring clinical trial data; downloadable electronic publications in the nature of brochures and newsletters in the field of clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; Downloadable podcasts in the field of clinical trials; downloadable computer software for accessing information and intelligence for use in clinical trial management; downloadable software featuring searchable databases for accessing clinical trial information; downloadable software for business management; downloadable software for data capture, data analysis, and data processing; downloadable software for document management; downloadable software for research management; blank USB flash drives; downloadable computer software to assist with clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; downloadable computer software to assist with sharing of clinical data and clinical trial results, accelerating clinical study recruitment, optimizing clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguard regulatory compliance in the nature of identifying and authenticating users in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfil and manage clinical data requests, track key performance indicators in relation to clinical trials, track industry benchmarks in relation to clinical trials, and provide clinical trial results summaries; downloadable database server software featuring databases in the field of clinical trial data; downloadable database server software featuring databases in relation to sharing of clinical data and clinical trial results, acceleration of clinical study recruitment, optimisation of clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguarding regulatory compliance in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries; downloadable database server software featuring databases in the field of clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; downloadable publications in the nature of magazines and journals the field of clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; downloadable publications the nature of magazines, journals, brochures and newsletters in the field of sharing of clinical data and clinical trial results, acceleration of clinical study recruitment, optimisation of clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguarding regulatory compliance in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries | ACTIVE | — |
| 035 | Advertising services; business management, business organization consulting and business administration; providing office functions; advertising and publicity services; rental of advertising space; arranging newspaper subscriptions for others; arranging subscriptions for the electronic journals of others; arranging subscriptions to information media of others, namely, arranging of subscriptions for the publications of others; arranging subscriptions for the publications of others; business and market research, analysis and data compilation; providing business intelligence services; business management; business networking; collection, systematization, compilation and analysis of business data and business information stored in computer databases; commercial information; compilation of business directories for business; computerized file management; database management; dissemination in the nature of compilation of information into computer databases, namely of business and market research; analysis and data compilation, namely, analyzing and compiling business data; market forecasting; market intelligence services; Conducting market surveys, market analysis and market research studies; news clipping services; organization and conducting of exhibitions for commercial or advertising purposes; organization and conducting of trade fairs for commercial or advertising purposes; public opinion polling; providing business information via global computer networks and the Internet; public relations; arranging subscriptions of the for the business publications of others; systematisation of data into computer databases; updating and maintenance of data in computer databases; arranging subscriptions to information media for others, namely, arranging of subscriptions for the publications of others in relation to clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; arranging subscriptions to information media for others, namely, arranging of subscriptions for the publications of others in relation to sharing of clinical data and clinical trial results, acceleration of clinical study recruitment, optimisation of clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguarding regulatory compliance in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries; Business research and market research, analysis and business data compilation in the field of clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management business and market research, analysis and data compilation in relation to sharing of clinical data and clinical trial results, acceleration of clinical study recruitment, optimisation of clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguarding regulatory compliance in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries; Providing business intelligence services in the field of clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; Providing business intelligence services in the field of clinical trials; Providing business intelligence services in the field of sharing of clinical data and clinical trial results, acceleration of clinical study recruitment, optimisation of clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguarding regulatory compliance in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries; organization and conducting exhibitions for commercial or advertising purposes in the field of clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; organization and conducting exhibitions for commercial or advertising purposes in the field of sharing of clinical data and clinical trial results, acceleration of clinical study recruitment, optimisation of clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguarding regulatory compliance in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries; organization and conducting of trade fairs for commercial or advertising purposes in the field of clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; organization and conducting of trade fairs for commercial or advertising purposes in the field of sharing of clinical data and clinical trial results, acceleration of clinical study recruitment, optimisation of clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguarding regulatory compliance in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet; compilation of information in the form of medical reports into computer databases | ACTIVE | — |
| 042 | Quality control for others and authentication services, namely, electronic document and e-mail authentication services in the field of clinical trials; design and development of computer hardware and software; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals and life sciences; computer network configuration services; computer programming; computer programming for data processing and communication systems; computer programming services for the protection of software; computer project management services in the field of electronic data processing; computer security services, namely, administering digital certificates for securing computer data; computer services in the nature of developing customized web pages featuring user-defined information in the nature of personal profiles and information in the field of pharmaceuticals and life sciences; consultancy and information services relating to information technology, namely, provision of information relating to computer technology via a website; database design and development; design and development of computer software systems for data input, output, processing, display and storage; design and development of computer software for testing and analysis methods; Software as a service (SAAS) services, namely, hosting software for use by others for use in managing clinical trial regulatory and market requirements, managing public disclosure of clinical trial information, project management, providing an operations dashboard, workflow management, document library management, task management and using business intelligence to manage clinical trials; hosting of digital content on the Internet, namely, online journals and blogs; computer services, namely, hosting online web sites of others for organising and conducting online meetings, gatherings, and conducting interactive discussions; hosting of web sites; Hosting internet sites for others featuring weblogs; industrial analysis and research services in the field of pharmaceuticals and life sciences; pharmaceutical research services; medical and pharmaceutical research services, namely, in vitro analysis for medical and pharmaceutical research; Platform as a service (PAAS) featuring computer software platforms for use in managing clinical trial regulatory and market requirements, managing public disclosure of clinical trial information, project management, providing an operations dashboard, workflow management, document library management, task management and using business intelligence to manage clinical trials; providing scientific research information and providing information in the field of clinical research results from an on-line searchable database; Providing a website featuring a search engine for obtaining data on a global computer network; Software as a service (SAAS) services featuring software for generating data reports for use in publishing and printing; Software as a service (SAAS) services featuring software for facilitating sponsors of clinical trials and suppliers of trial participants by exchanging trial data and information for the purpose of trial recruitment; technical scientific research; hosting of digital content on the internet, namely, online journals and blogs in relation to clinical trial disclosure management, clinical trial communications, patient referrals, clinical trial recruitment, clinical trial data, managing clinical data requests, clinical record management; Software as a service (SAAS) services featuring software for clinical trial disclosure management, enabling clinical trial communications, managing patient referrals, managing clinical trial recruitment, managing clinical trial data, managing clinical data requests, clinical record management; hosting of digital content on the internet, namely, online journals and blogs in relation to sharing of clinical data and clinical trial results, acceleration of clinical study recruitment, optimisation of clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguarding regulatory compliance in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries; Software as a service (SAAS) services featuring software for sharing of clinical data and clinical trial results, accelerating clinical study recruitment, optimizing clinical study spending, building clinical trial awareness and reputation, automating and simplifying global clinical trial disclosure, safeguard regulatory compliance in the nature of identifying and authenticating users in relation to clinical trials, mitigating risk in clinical trials, assisting with disclosure activities and compliance in relation to clinical trials, fulfilling and managing clinical data requests, tracking key performance indicators in relation to clinical trials, tracking industry benchmarks in relation to clinical trials, and providing clinical trial results summaries; information, consultancy, and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet | ACTIVE | — |
| 044 | Advisory services relating to pharmaceuticals, namely, pharmaceutical advice; health care services; Providing medical information to patients and medical professionals in the form of reports in the field of clinical trials; medical analysis services relating to the treatment of patients; medical services; information, consultancy, and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Informa Business Intelligence, Inc.
- Other trademarks owned by Caerus US 1 Inc.
- Other trademarks owned by Caerus US 1 Inc.
- Other trademarks owned by Caerus US 1 Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TRIALSCOPE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 20, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 3, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 2, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 20, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 20, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 5, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 5, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 15, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 15, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 15, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 25, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 25, 2023 | ALIE | ASSIGNED TO LIE | — |
| May 30, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 26, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 10, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 10, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 30, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 4, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 5, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 19, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 19, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 9, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 8, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 14, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |